InvestorsHub Logo
Followers 4
Posts 479
Boards Moderated 0
Alias Born 01/03/2015

Re: Amatuer17 post# 218931

Sunday, 02/25/2018 1:05:49 PM

Sunday, February 25, 2018 1:05:49 PM

Post# of 403036
January 16, 2018 PR

At recent San Francisco show:

Brilacidin-OM received an exceptional degree of attention.

A robust partnering matrix.

Brilacidin has earned a leadership position as an easily-delivered oral rinse drug candidate in OM

A $1 billion market opportunity within the next few years.

“What must be stressed is that Brilacidin is a mature, later-stage drug candidate with platform potential.

A newfound flurry of inbound partnership discussions at the San Francisco conferences

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News